Peng Yang

CDISC, Clinical Data Management, Biostatistics and Programming, CRO Oversight.
Peng

Peng Yang

President, Clindata Insight Inc. 

Peng has spent 20 years supporting clinical trial projects, with extensive biometrics experience in all phases of clinical development and medical affairs within the pharmaceutical and biotechnology industry. In 2013, she founded Clindata Insight Inc, a niche consulting business in biometrics and grew the business into a premier data service provider, winning numerous awards, including the Top 100 Women Owned Businesses in the Bay Area in 2019 through 2022. She attracted and developed a team of experts who provide the gold standard of consulting services in CDISC implementation, clinical data management, biostatistics, statistical programming, and CRO oversight.

Before founding Clindata Insight, she worked for pharmaceutical companies in various management roles. She was the Head of Statistical Programming and Data Management at Santen Inc, where she built the statistical programming functionality from the ground up. She was also the Manager of Statistical Programming and Global Product Lead Programmer at Amgen, where she led a global programming team to support the GCSF franchise.

Peng is a member of American Statistical Association (San Francisco & BIOP chapter) and Women Presidents' Organization (WPO). She is also a co-founder of the non-profit data science focused organization DahShu in the Silicon Valley. She has given numerous talks on career development and entrepreneurship.

Peng holds a Master's of Science in Computer Science from the University of Texas at Dallas and a Master's of Science in Genetics and Developmental Biology from the University of Texas Southwestern Medical Center in Dallas. She received her Bachelor's of Science in Biotechnology from Peking University.